These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21868824)

  • 1. Advances in antiretroviral therapy.
    Taylor B; Olender S; Wilkin TJ; Hammer SM
    Top Antivir Med; 2011; 19(2):69-97. PubMed ID: 21868824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in antiretroviral therapy.
    Wilkin TJ; Shalev N; Tieu HV; Hammer SM
    Top HIV Med; 2010; 18(2):66-92. PubMed ID: 20516526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in antiretroviral therapy.
    Wilkin TJ; Taylor B; Olender S; Hammer SM
    Top HIV Med; 2009; 17(2):68-88. PubMed ID: 19401609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global status of resistance to antiretroviral drugs.
    Vella S; Palmisano L
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S239-46. PubMed ID: 16032559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in antiretroviral drugs.
    Ghosh RK; Ghosh SM; Chawla S
    Expert Opin Pharmacother; 2011 Jan; 12(1):31-46. PubMed ID: 20698725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
    Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
    N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CROI 2016: Advances in Antiretroviral Therapy.
    Taylor BS; Olender SA; Tieu HV; Wilkin TJ
    Top Antivir Med; 2016; 24(1):59-81. PubMed ID: 27398863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of antiretroviral failure and resistance in developing countries.
    Hawkins C; Murphy RL
    Curr Opin HIV AIDS; 2009 Nov; 4(6):538-44. PubMed ID: 20048723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reformulation of existing antiretroviral drugs.
    Gogtay JA; Malhotra G
    Curr Opin HIV AIDS; 2013 Nov; 8(6):550-5. PubMed ID: 24100875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of antiretroviral treatment.
    Bailey AC; Fisher M
    Br Med Bull; 2008; 87():175-92. PubMed ID: 18757468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observance of antiretroviral treatments: African specificities].
    Eholié SP; N'dour CT; Cissé M; Bissagnéné E; Girard PM
    Med Mal Infect; 2006 Sep; 36(9):443-8. PubMed ID: 17027212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric aspects of HIV1-infection--an overview.
    Buchholz B; Hien S; Weichert S; Tenenbaum T
    Minerva Pediatr; 2010 Aug; 62(4):371-87. PubMed ID: 20940671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy of late presenters with advanced HIV disease.
    Battegay M; Fehr J; Flückiger U; Elzi L
    J Antimicrob Chemother; 2008 Jul; 62(1):41-4. PubMed ID: 18408235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of treatment failure: a focus on recent trends.
    Hull MW; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    Curr Opin HIV AIDS; 2009 Nov; 4(6):467-73. PubMed ID: 20048712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.